SESSAREGO, MARIO
 Distribuzione geografica
Continente #
EU - Europa 8.796
AS - Asia 807
NA - Nord America 733
SA - Sud America 70
Continente sconosciuto - Info sul continente non disponibili 32
AF - Africa 13
OC - Oceania 2
Totale 10.453
Nazione #
IT - Italia 8.650
US - Stati Uniti d'America 688
SG - Singapore 345
CN - Cina 218
VN - Vietnam 125
FR - Francia 68
BR - Brasile 39
BD - Bangladesh 34
HK - Hong Kong 30
AR - Argentina 14
JP - Giappone 14
MX - Messico 14
DE - Germania 13
CA - Canada 11
CH - Svizzera 11
FI - Finlandia 11
GB - Regno Unito 10
IQ - Iraq 10
ID - Indonesia 7
EC - Ecuador 6
NL - Olanda 6
IN - India 5
JM - Giamaica 5
CO - Colombia 4
ES - Italia 4
RU - Federazione Russa 4
VE - Venezuela 4
ZA - Sudafrica 4
IE - Irlanda 3
KZ - Kazakistan 3
TR - Turchia 3
AU - Australia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
MA - Marocco 2
PK - Pakistan 2
PL - Polonia 2
PY - Paraguay 2
RS - Serbia 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BE - Belgio 1
BS - Bahamas 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LT - Lituania 1
LV - Lettonia 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SE - Svezia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 10.421
Città #
Genova 5.534
Genoa 1.805
Rapallo 748
Vado Ligure 505
San Jose 175
Singapore 149
Ashburn 98
Lauterbourg 62
New York 43
Ho Chi Minh City 38
Hong Kong 29
Hanoi 26
Beijing 25
Los Angeles 20
Santa Clara 17
Dallas 15
Bordighera 13
Tokyo 12
Buffalo 11
Frankfurt am Main 11
Helsinki 11
Orem 11
Zurich 11
Atlanta 8
Memphis 8
Mexico City 8
San Francisco 8
São Paulo 7
Chicago 6
Tianjin 6
Amsterdam 5
Baghdad 5
Haiphong 5
Hải Dương 5
Naples 5
Brooklyn 4
Philadelphia 4
Rome 4
Secaucus 4
Biên Hòa 3
Boston 3
Cardiff 3
Da Nang 3
Denver 3
Dublin 3
Kingston 3
Montreal 3
Paris 3
Phoenix 3
Piscataway 3
Portland 3
Resistencia 3
Anaheim 2
Antakya 2
Augusta 2
Bari 2
Belgrade 2
Bologna 2
Bắc Ninh 2
Can Tho 2
Canton 2
Costa Mesa 2
Florence 2
Greensboro 2
Hudson 2
Iowa City 2
Lake Ariel 2
Lansdowne 2
Leander 2
London 2
Nairobi 2
Newark 2
Ocala 2
Piacenza 2
Poplar 2
Princeton 2
Quincy 2
Quito 2
Raleigh 2
Rockford 2
Seattle 2
South Jordan 2
Staten Island 2
Stockbridge 2
Sydney 2
Temecula 2
Toronto 2
Tosno 2
Turin 2
Vĩnh Long 2
Warsaw 2
Washington 2
Acalanes Ridge 1
Addis Ababa 1
Aguascalientes 1
Ahmedabad 1
Al Hillah 1
Allegheny County 1
Almaty 1
Amman 1
Totale 9.588
Nome #
HMGA2 overexpression in plycythemia vera with t(12;21) (q14;q22) 261
High frequency of trisomy 8 in acute promyelocytic leukemia: a fluorescence in situ hybridization study. 233
Association of -318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis. 230
A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia 223
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients 220
Allogeneic bone marrow transplantation (BMT) for adults with acute lymphoblastic leukemia (ALL): predictive role of minimal residual disease monitoring on relapse 219
Uncommon cytogenetic findings in a case of splenic marginal zone lymphoma with aggressive clinical course 212
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients 210
AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis 203
High-dose chemotherapy with tandem autologous transplantation as part of the initial therapy for aggressive non-Hodgkin's lymphoma 199
Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study 199
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromes 198
Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF 195
Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes. 191
Effects of three cytokine regimens on hematologic recovery and progenitor cell mobilization after high-dose cyclophosphamide, etoposide, and cisplatin. 181
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule 177
A case of chronic myelogenous leukemia with unusual chromosomal abnormality. 174
First line therapy with Fludarabine combinations in 42 patients with either post-myelodysplastic syndrome or therapy related acute myeloid leukaemia. 171
Spontaneous exodus of high numbers of normal early progenitor cells (Ph-negative LTC-IC) in the peripheral blood of patients with chronic myeloid leukaemia at the beginning of the disease. 170
Amplified c-MYC sequences localized by fluorescence in-situ hybridization on double minute chromosomes in acute myeloid leukemias. 170
Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker 165
Standard and variant Philadelphia translocation in a CML patient with different sensitivity to imatinib therapy. 163
Molecular analysis of the bcr rearrangement in a case of Ph'-negative blastic crisis of Ph'-positive chronic myelogenous leukemia. 160
Complex structural involvement of chromosome 7 in primary myelodysplastic syndromes determined by fluorescence in situ hybridization. 159
Fluorescence in situ hybridization provides evidence for two-step rearrangement in a masked Ph chromosome formation. 158
Molecular analysis of the Imatinib-induced complete cytogenetic response in chronic myelogenous leukemia 153
Variant Philadelphia translocations in CML: correlation with fragile sites. 150
Cardiac magnetic resonance imaging detects subclinical right ventricular impairment in systemic sclerosis 149
Four-step high-dose sequential chemotherapy with double hematopoietic progenitor cell rescue for metastatic breast cancer 147
Autografting with Ph-negative progenitors in patients at diagnosis of chronic myeloid leukemia induces a prolonged prevalence of Ph-negative hemopoiesis 147
Small intestinal bacterial overgrowth in patients suffering from scleroderma: clinical effectiveness of its eradication 145
Complex chromosome rearrangements may locate the bcr/abl fusion gene sites other than 22q11 145
Assocition of -318C/T and +49A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of italian patients with systemic sclerosis 144
Duplication of the der(13)t(12;13)(p13;q14) in chronic myelomonocytic leukemia. 144
On the Xq13 breakpoint: clinical and cytogenetic observations in a patient with acute myelogenous leukemia. 144
Autografting with Philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia 143
Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients. 142
Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. 141
Expression and genomic configuration of GM-CSF, IL-3, M-CSFreceptor (C-FMS), early growth response gene-1 (EGR-1) and M-CSF genes in primary myelodysplastic syndromes 141
WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia. 140
Unusual Ph translocations in CML: four new cases 138
Masked Philadelphia chromosome due to atypical BCR/ABL localization on the 9q34 band and duplication of the der(9) in a case of chronic myelogenous leukemia 138
Karyotype evolution in a case of chronic myelogenous leukemia with an unusual Philadelphia chromosome translocation, t(4;22), and an additional translocation, t(3;5). 135
Masked Philadelphia chromosome caused by translocation (9;11;22) 134
Variant Philadelphia chromosome translocations are frequently associated with additional structural abnormalities. 131
Normal primitive haemopoietic progenitors are more frequent than their leukaemic counterpart in newly diagnosed patients with chronic myeloid leukaemia but rapidly decline with time 126
Preparation of colony stimulating activity from human leukemic urine: hydrophobic chromatography on propylamine-agarose. 126
Cytogenetic clonality in chronic myelomonocytic leukemia studied with fluorescence in situ hybridization 122
Thrombocytosis in subjects with chronic myelocytic leukemia in blastic metamorphosis. Clinical remarks and therapeutic considerations (5 case reports). 119
High efficacy of fludarabine-containing therapy (FLAG-FLANG) in poor risk acute myeloid leukemia. 119
Related Articles, Links Autografting with philadelphia chromosome-negative mobilized hematopoietic progenitor cells in chronic myelogenous leukemia. 117
Composition of human granulocytic colonies as a function of the purification stage of CSF. 115
Demonstration of phosphoglucomutase 1 in a subclone of the K-562 cell line 114
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia 112
Coincidence between fragile site expression and interstitial deletion ofchromosome 11 in a case of myelofibrosis 111
Erythroid differentiation of erythroleukemic line K562 (S) with arabinofuranosylcytosine: isolation of a non inducible clone. 111
Mixed chimerism after allogeneic marrow transplantation. 108
The dose of total body irradiation (TBI), and GvHD prophilaxis have a crucial role on relapse risk and survival after BMT for leukaemia. 107
Urinary colony-stimulating factor in acute leukemia follow-up and correlation with various phases of the disease. 107
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: long-term follow-up of patients treated at S. Martino Hospital, Genoa 105
Marked karyotype abnormalities in two cases of acute myelogenous leukemia. 104
Expression of erythroid acetylcholinesterase in the K-562 leukemia cell line 100
Trisomy 8 detection in Ph+ CML patients using conventional cytogenetic and interphase fluorescence in situ hybridization techniques. 99
Marrow colony stimulating activity in chronic myelogenous leukemia. 98
Interferon-alpha protects Philadelphia-negative progenitors from exhaustion in chronic myeloid leukemia patients with cytogenetic response. 98
Fibroblastoid colony-forming cells in myeloproliferative disorders. 97
Isolation and characterization of a K562 cell lineresistant to 1-beta-D-arabinofuranosylcytosine-mediated erythroid induction. 96
Multivariate analysis of risk factors for survival and relapse in chronic granulocytic leukemia following allogeneic marrow transplantation: impact of disease related variables (Sokal score). 93
Regulation of acetylcholinesterase expression in the K-562 cell line 90
Monitoring molecular response by BCR-ABL, JH and WT-1 in Ph+ all treated with imatinib containing regimen: preliminary report of two cases. 86
Mixed chimerism after allogeneic marrow transplantation for leukaemia: correlation with dose of total body irradiation and graft-versus-host disease. 81
Totale 10.453
Categoria #
all - tutte 30.548
article - articoli 30.548
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.096


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022844 21 41 79 90 39 69 36 201 40 91 24 113
2022/2023890 93 71 15 98 159 169 0 62 148 5 66 4
2023/2024428 23 55 8 50 25 114 24 37 19 5 21 47
2024/20251.208 25 114 43 61 170 119 94 197 54 49 132 150
2025/20262.170 311 84 55 146 274 224 418 89 122 185 160 102
2026/2027191 191 0 0 0 0 0 0 0 0 0 0 0
Totale 10.453